Shiloh
Editor, Senior Moderator
Source: http://www.ctv.ca/servlet/ArticleNe...1/vaccine_flu091021/20091021?hub=TopStoriesV2
Health Canada approves H1N1 swine flu vaccine
CTV.ca News Staff
Date: Wednesday Oct. 21, 2009 11:13 AM ET
CTV News has learned that Health Canada has approved the H1N1 vaccine, meaning the first Canadians to receive the shot could be vaccinated as early as the end of the week.
Two million doses of the vaccine have already been shipped to the provinces and territories, but health officials had to wait for regulatory approval before they were able to give the go-ahead.
All Canadians can access the vaccine, unlike in the United States, which so far has only about 40 million doses for a population of 300 million.
Federal officials in Canada meanwhile have ordered 50.4 million doses of the vaccine, which contains an adjuvant, a compound that will boost immune system response and that Canada has never approved before in a flu vaccine.
Another 1.8 million doses of the vaccine without the adjuvant are also on the way, though the timing of when that will be available remains unclear. That vaccine must be manufactured, packaged and shipped separately.
Canadian clinical trials of the vaccine are still underway, and the results won't be available until next year. So federal health authorities have relied on data from clinical trials done on the same vaccine in Europe. Those trials have found the vaccine safe.
The adjuvant used in Canada's swine flu vaccine, AS03, has also been tested in about 45,000 people around the world using a "mock" H5N1 vaccine. No significant safety concerns were detected, Health Canada reports.
The Canadian clinical trials are focused on determining the safety and effectiveness of the vaccine in select population groups, such as First Nations, people who are HIV positive, children and pregnant women.
Because some reactions from vaccines are so rare they arise in only one in a million cases, the final picture of the vaccine's safety won't be clear until after the immunization program is underway
Dr. David Butler-Jones, Canada's chief public health officer, says that while pregnant women are encouraged to receive the vaccine without the adjuvant, the vaccine with adjuvant is still considered safe for expectant mothers.
While there have been few studies of adjuvanted flu vaccine on pregnant women, the risks are only theoretical, whereas the risk of swine flu to pregnant women are real and significant, Butler-Jones has said.
"The risks to pregnant women from contracting H1N1 are much, much higher than any theoretical risk posed by adjuvanted vaccine," he said earlier this week.
About 4,700 people worldwide have died of H1N1 to date, including 83 deaths in Canada.
The Public Health Agency of Canada says everyone aged six months and older should get the vaccine, but those who will benefit most and those who care for them include:
* People under 65 with chronic health conditions
* Pregnant women
* Children aged six months to less than five years
* People in remote and isolated communities
* Health care workers involved in the delivery of essential health care services
* Household contacts and care providers of persons at high risk who cannot be immunized
The vaccine will be distributed by the provinces and available through flu clinics offered by local health units.
Health Canada approves H1N1 swine flu vaccine
CTV.ca News Staff
Date: Wednesday Oct. 21, 2009 11:13 AM ET
CTV News has learned that Health Canada has approved the H1N1 vaccine, meaning the first Canadians to receive the shot could be vaccinated as early as the end of the week.
Two million doses of the vaccine have already been shipped to the provinces and territories, but health officials had to wait for regulatory approval before they were able to give the go-ahead.
All Canadians can access the vaccine, unlike in the United States, which so far has only about 40 million doses for a population of 300 million.
Federal officials in Canada meanwhile have ordered 50.4 million doses of the vaccine, which contains an adjuvant, a compound that will boost immune system response and that Canada has never approved before in a flu vaccine.
Another 1.8 million doses of the vaccine without the adjuvant are also on the way, though the timing of when that will be available remains unclear. That vaccine must be manufactured, packaged and shipped separately.
Canadian clinical trials of the vaccine are still underway, and the results won't be available until next year. So federal health authorities have relied on data from clinical trials done on the same vaccine in Europe. Those trials have found the vaccine safe.
The adjuvant used in Canada's swine flu vaccine, AS03, has also been tested in about 45,000 people around the world using a "mock" H5N1 vaccine. No significant safety concerns were detected, Health Canada reports.
The Canadian clinical trials are focused on determining the safety and effectiveness of the vaccine in select population groups, such as First Nations, people who are HIV positive, children and pregnant women.
Because some reactions from vaccines are so rare they arise in only one in a million cases, the final picture of the vaccine's safety won't be clear until after the immunization program is underway
Dr. David Butler-Jones, Canada's chief public health officer, says that while pregnant women are encouraged to receive the vaccine without the adjuvant, the vaccine with adjuvant is still considered safe for expectant mothers.
While there have been few studies of adjuvanted flu vaccine on pregnant women, the risks are only theoretical, whereas the risk of swine flu to pregnant women are real and significant, Butler-Jones has said.
"The risks to pregnant women from contracting H1N1 are much, much higher than any theoretical risk posed by adjuvanted vaccine," he said earlier this week.
About 4,700 people worldwide have died of H1N1 to date, including 83 deaths in Canada.
The Public Health Agency of Canada says everyone aged six months and older should get the vaccine, but those who will benefit most and those who care for them include:
* People under 65 with chronic health conditions
* Pregnant women
* Children aged six months to less than five years
* People in remote and isolated communities
* Health care workers involved in the delivery of essential health care services
* Household contacts and care providers of persons at high risk who cannot be immunized
The vaccine will be distributed by the provinces and available through flu clinics offered by local health units.